| Elekta’s Executive Committee consists of the President and CEO, the Chief Financial Officer, the Chief Operating Officer, the managers of four product areas and the three regions – a total of nine members. The President and CEO oversees the work of the Executive Committee and makes decisions after consulting with the members. Executive Committee meetings are held one or two days each month. The meetings are often held in conjunction with visits to the Group’s various units. Details regarding remuneration for the President and CEO and Executive Committee are provided in note 5 in the Annual Report 2010/11. President and CEO |  | Tomas Puusepp Born: 1955 President and CEO Employed since 1988 Holdings: 150,000 B-shares, 41,593 employee options | Executive Committee |  | Olof Sandén Born: 1962 Executive Vice President, Region Europe, Africa, Latin America, Middle East Employed 1993–1995 and since 2002 Holdings: 8,639 B-shares, 89,432 employee options | | | | | Gilbert Wai Born: 1953 Executive Vice President, Region Asia Pacific Employed since 1998 Holdings: 110,100 B-shares | | | |  | Åsa Hedin Born: 1962 Executive Vice President, Elekta Neuroscience Employed 1994–2000 and since 2007 Holdings: 327 B-shares, 74,432 employee options | | | |  | Johan Sedihn Born: 1965 Executive Vice President, Elekta Oncology Employed since 1993 Holdings: 19,753 B-shares, 89,432 employee options | | | |  | James P. Hoey Born: 1955 Executive Vice President, Region North America Employed since 2005 (Founded IMPAC 1990) Holdings: 1,500 B-shares, 89,432 employee options | | | |  | Todd Powell Born: 1965 Executive Vice President, Elekta Software Employed since 2005 (Employed at IMPAC since 1992) Holdings: 3,239 B-shares, 27,773 employee options | | | |  | Håkan Bergström Born: 1956 CFO Employed since 2001 Holdings: 35,013 B-shares, 69,432 employee options | | | |  | Jos Lamers Born: 1963 Executive Vice President Brachytherapy Solutions Employed since 2011 (CEO of Nucletron since 2008) Holdings: - | | | | | President and CEO | The President and CEO is appointed by the Board of Directors and shall oversee the operational management of Elekta in accordance with the guidelines and directions stated in law, the articles of association and the internal operating instructions. Operational management includes all measures that are not – considering the scope and nature of the Company’s operations – of an unusual nature or of major significance, or are explicitly defined as being the responsibility of the Board of Directors. Tomas Puusepp has served as President and CEO of Elekta since 1 May, 2005. Born in 1955, he has a total of 28 years of experience in international medical technology. Following studies in engineering and physics and management training at IMD in Lausanne, Switzerland, Tomas Puusepp held various positions at the Research Institute for Atomic Physics, Scanditronix and Ericsson before being employed by Elekta in 1988. Since then, he has held various management positions within the Company, including head of Elekta’s neurosurgery operations, President of Elekta’s subsidiary in North America and global head of Elekta’s sales, marketing and service operations. | |